G. Atalay

412 total citations
12 papers, 317 citations indexed

About

G. Atalay is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Atalay has authored 12 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Atalay's work include HER2/EGFR in Cancer Research (4 papers), Estrogen and related hormone effects (3 papers) and Cancer Treatment and Pharmacology (3 papers). G. Atalay is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Estrogen and related hormone effects (3 papers) and Cancer Treatment and Pharmacology (3 papers). G. Atalay collaborates with scholars based in Belgium, Slovenia and United Kingdom. G. Atalay's co-authors include Fátima Cardoso, Ahmad Awada, M. Piccart, Martine Piccart, Laura Biganzoli, Tanja Čufer, Robert Paridaens, Robert E. Coleman, Teresa Gamucci and Françoise Renard and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Anti-Cancer Drugs.

In The Last Decade

G. Atalay

11 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Atalay Belgium 7 182 82 82 72 63 12 317
Alan Mackay United Kingdom 7 114 0.6× 31 0.4× 55 0.7× 37 0.5× 80 1.3× 13 254
Aurélie Ferru France 11 250 1.4× 26 0.3× 86 1.0× 82 1.1× 93 1.5× 30 439
J-M Ferrero France 10 215 1.2× 40 0.5× 74 0.9× 135 1.9× 75 1.2× 41 319
Rico D. Bense Netherlands 8 298 1.6× 46 0.6× 141 1.7× 166 2.3× 177 2.8× 9 508
Benjamin Bonhomme France 8 131 0.7× 24 0.3× 44 0.5× 81 1.1× 45 0.7× 15 261
Zhiqiang Mo China 10 153 0.8× 86 1.0× 204 2.5× 68 0.9× 246 3.9× 23 466
Harish Kumar United Kingdom 8 237 1.3× 25 0.3× 148 1.8× 81 1.1× 290 4.6× 18 453
Inge Platteel Netherlands 11 157 0.9× 43 0.5× 237 2.9× 75 1.0× 290 4.6× 15 500
Alexander B. Sibley United States 12 171 0.9× 17 0.2× 71 0.9× 80 1.1× 124 2.0× 27 393
Christos Mikropoulos United Kingdom 11 286 1.6× 41 0.5× 101 1.2× 179 2.5× 175 2.8× 21 483

Countries citing papers authored by G. Atalay

Since Specialization
Citations

This map shows the geographic impact of G. Atalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Atalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Atalay more than expected).

Fields of papers citing papers by G. Atalay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Atalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Atalay. The network helps show where G. Atalay may publish in the future.

Co-authorship network of co-authors of G. Atalay

This figure shows the co-authorship network connecting the top 25 collaborators of G. Atalay. A scholar is included among the top collaborators of G. Atalay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Atalay. G. Atalay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Atalay, Can, et al.. (2005). The role of anti-CENP-B and anti-SS-B antibodies in breast cancer.. PubMed. 52(1). 32–5. 25 indexed citations
3.
Mano, Max S., Ahmad Awada, G. Atalay, et al.. (2004). Remaining controversies in the upfront management of advanced ovarian cancer. International Journal of Gynecological Cancer. 14(5). 707–720. 6 indexed citations
4.
Mano, Max S., Ahmad Awada, G. Atalay, et al.. (2004). Remaining controversies in the upfront management of advanced ovarian cancer. International Journal of Gynecological Cancer. 14(5). 707–720. 18 indexed citations
5.
6.
Atalay, G., Fátima Cardoso, Ahmad Awada, & M. Piccart. (2003). Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Annals of Oncology. 14(9). 1346–1363. 87 indexed citations
7.
Atalay, G., Fátima Cardoso, M. Paesmans, R. M. Goldberg, & Harry Bleiberg. (2003). Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?. Anti-Cancer Drugs. 14(9). 703–713. 4 indexed citations
8.
9.
Atalay, G., Laura Biganzoli, Françoise Renard, et al.. (2003). Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. European Journal of Cancer. 39(17). 2439–2449. 83 indexed citations
10.
Atalay, G., Laura Biganzoli, Françoise Renard, et al.. (2002). Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. UCL Discovery (University College London). 1 indexed citations
11.
Leo, Angelo Di, Fátima Cardoso, Virginie Durbecq, et al.. (2002). Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002. International Journal of Clinical Oncology. 7(4). 245–253. 10 indexed citations
12.
Piccart, M., Fátima Cardoso, & G. Atalay. (2002). Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer. European Journal of Cancer. 38. 52–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Mackay Breakdown of academic impact, for papers by Aurélie Ferru Breakdown of academic impact, for papers by J-M Ferrero Breakdown of academic impact, for papers by Rico D. Bense Breakdown of academic impact, for papers by Benjamin Bonhomme Breakdown of academic impact, for papers by Zhiqiang Mo Breakdown of academic impact, for papers by Harish Kumar Breakdown of academic impact, for papers by Inge Platteel Breakdown of academic impact, for papers by Alexander B. Sibley Breakdown of academic impact, for papers by Christos Mikropoulos
Rankless by CCL
2026